The AMD Center

Filter Your Results




Targeting the Visual Cycle: Dry AMD and Stargardt Disease

Aron Shapiro; David Hollander, MD, MBA; and Andrew Hertsenberg, PhD

November/December 2016—The visual cycle could be the crucible for treating two important degenerative eye diseases.

Recapping the Past 12 Months

the staff of Retina Today

November/December 2016—We are at the tail end of another successful year for the retina world. It is pretty amazing that one area of the eye care industry can continue to grow and expand as much as …

Gene Therapy in a Drop

Kuan Jiang and Gang Wei, PhD, with editorial commentary from Szilárd Kiss, MD

October 2016—The lowdown on an investigational, noninvasive gene delivery system for the treatment of retinal disease.

A Team-Based Approach to Treating Advanced Macular Degeneration

Sundeep K. Kasi, MD, and Carl D. Regillo, MD

September 2016—The combination of candidate selection, occupational therapy, and Implantable Miniature Telescope surgery is not a one-person job.

CATT 5-Year Data: Our Perspective

Allen C. Ho, MD, and Robert L. Avery, MD

July/August 2016— The CATT was a groundbreaking comparative trial that showed statistical equivalence of bevacizumab (Avastin, Genentec

Visual Function Biomarkers Needed for Dry AMD

Aron Shapiro

July/August 2016—Early detection may allow treatment and possible reversal. Part 1 of a 2-part series.

The Promise of Integrin Receptors for Treating Vitreoretinal Disorders

Victor H. Gonzalez, MD

July/August 2016—Study results suggest this class of drug has vitreolytic activity and a longer duration of effect than current treatments.

An Oral Drug for Treatment of AMD?

Carl C. Awh, MD

July/August 2016—The potential for this proposed treatment option could be significant for many patients and their caregivers.


This Month's Supplements


Contact Info

Bryn Mawr Communications LLC
1008 Upper Gulph Road, Suite 200
Wayne, PA 19087

Phone: 484-581-1800
Fax: 484-581-1818

Karen Roman

Janet Burk

About Retina Today

Retina Today is a publication that delivers the latest research and clinical developments from areas such as medical retina, retinal surgery, vitreous, diabetes, retinal imaging, posterior segment oncology and ocular trauma. Each issue provides insight from well-respected specialists on cutting-edge therapies and surgical techniques that are currently in use and on the horizon.